Ada Health
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $120M
Investors
- 9
About Ada Health
a. Ada is a health technology company that provides an artificial intelligence enabled mobile application to diagnose symptoms and control health issues by giving suggestions and information. Ada Health GmbH provides an AI-based health assessment and care navigation platform, Ada application, that helps individuals to understand their symptoms, identify and differentiate conditions with medical accuracy, and navigate safely to the right care. As of October 2021, the Ada app has completed 25 million symptom assessments of 10 million users across 7 languages. In addition, the company offers medical insights across research, product development and online medical content, which is peer-reviewed, regularly updated, and easy to understand.
Who invested in Ada Health
9 investors across 2 rounds
See all investors in Ada Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ada Health
Who invested in Ada Health?
Ada Health has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ada Health raised?
Ada Health has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ada Health last raise money?
Ada Health's most recent round on record is a Series B, in Feb 2022.
What does Ada Health do?
Ada Health is a healthcare it company.
Where is Ada Health headquartered?
Ada Health is headquartered in Berlin, Germany.
Which VCs invest in companies like Ada Health?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Ada Health's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Ada Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.